Latest Breaking News On - Prnewswire syndax pharmaceuticals nasdaq - Page 1 : comparemela.com

Syndax to Announce First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 8, 2024

/PRNewswire/ Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today.

Sharon klahrePrnewswire syndax pharmaceuticals nasdaqSyndax pharmaceuticalsInternational numberSyndax pharmaceuticals incDial in numberMedical pharmaceuticalsHealth care amp hospitalsConference call announcements

Syndax Announces Completion of Enrollment in AUGMENT-101 Pivotal Trial Cohort of Patients with Relapsed/Refractory mNPM1 Acute Myeloid Leukemia

– Topline data expected in 4Q24 could support sNDA filing in 1H25 –

United statesNeil gallagherMichaela metzgerSharon klahreSyndax pharmaceuticalsDrug administrationPrnewswire syndax pharmaceuticals nasdaqAmerican society of hematology annual meetingExchange commissionHead of researchSyndax pharmaceuticals incEuropean commissionNew drug applicationChief executive officerPrescription drug user fee actAmerican society

Syndax Highlights Recent Updates and Anticipated 2024 Milestones

Syndax Highlights Recent Updates and Anticipated 2024 Milestones
kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.

United statesSharon klahreMichaela metzgerLeukemia lymphoma society beatSyndax pharmaceuticals incMd anderson cancer centerEuropean commissionDrug administrationAmerican society of hematology annual meetingAmerican society of hematologyExchange commissionSyndax pharmaceuticalsPrnewswire syndax pharmaceuticals nasdaqCompany updatesAmerican societyHematology annual meeting

Syndax Announces Presentation at 42nd Annual J P Morgan Healthcare Conference

Syndax Announces Presentation at 42nd Annual J P Morgan Healthcare Conference
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Sharon klahreMichaela metzgerSyndax pharmaceuticals incPrnewswire syndax pharmaceuticals nasdaqSyndax pharmaceuticalsChief executive officerHealthcare conference

Syndax Announces Presentation at 42nd Annual J P Morgan Healthcare Conference

Syndax Pharmaceuticals , a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer of Syndax, will present at the 42nd Annual J.P. Morgan.

Michaela metzgerSharon klahrePrnewswire syndax pharmaceuticals nasdaqSyndax pharmaceuticalsSyndax pharmaceuticals incAnnounces presentationChief executive officerHealthcare conference